Dusseldorf - Delayed Quote EUR

Viridian Therapeutics Inc (1S1.DU)

Compare
11.60 +0.10 (+0.87%)
As of 4:30 PM GMT+2. Market Open.
Loading Chart for 1S1.DU
DELL
  • Previous Close 11.50
  • Open 11.60
  • Bid 11.50 x --
  • Ask 12.00 x --
  • Day's Range 11.60 - 11.60
  • 52 Week Range 10.10 - 23.00
  • Volume --
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 1S1.DU

View More

Performance Overview: 1S1.DU

Trailing total returns as of 6/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

1S1.DU
41.12%
S&P 500
14.89%

1-Year Return

1S1.DU
44.23%
S&P 500
25.16%

3-Year Return

1S1.DU
57.35%
S&P 500
39.86%

5-Year Return

1S1.DU
57.35%
S&P 500
39.86%

Compare To: 1S1.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1S1.DU

View More

Valuation Measures

Annual
As of 6/27/2024
  • Market Cap

    763.74M

  • Enterprise Value

    396.30M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.11k

  • Price/Book (mrq)

    2.05

  • Enterprise Value/Revenue

    1.47k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1S1.DU

View More

Company Insights: 1S1.DU

Research Reports: 1S1.DU

View More